Cargando…
Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study
BACKGROUND: Standard chemotherapy for advanced non-small-cell lung cancer (NSCLC) with preexisting interstitial lung disease (ILD) has not yet been established. Although a combination of carboplatin and paclitaxel is most frequently used for patients with advanced NSCLC and ILD, the safety and effic...
Autores principales: | Araya, Tomoyuki, Kita, Toshiyuki, Ueda, Tsukasa, Terada, Nanao, Sakai, Tamami, Yamamura, Kenta, Kurokawa, Koji, Uchida, Yuka, Sone, Takashi, Kimura, Hideharu, Kasahara, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446117/ https://www.ncbi.nlm.nih.gov/pubmed/31015884 http://dx.doi.org/10.1155/2019/5315903 |
Ejemplares similares
-
Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab−Paclitaxel and Maintenance Monotherapy with nab−Paclitaxel: Two Case Reports
por: Araya, Tomoyuki, et al.
Publicado: (2020) -
Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study
por: Matsuoka, Hiroki, et al.
Publicado: (2021) -
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma
por: Takahashi, Akiko, et al.
Publicado: (2022) -
Repetitive responses to nanoparticle albumin‐bound paclitaxel and carboplatin in malignant pleural mesothelioma
por: Kanai, Osamu, et al.
Publicado: (2016) -
Large lung mass lesion with spontaneous regression in a patient with IgG4‐related lung disease
por: Iwasaki, Kazuhiko, et al.
Publicado: (2022)